LifeSci Acquisition II Corp. LSAQ
9.01 0.00 (+0.00%)
At closeOct 7, 2021, 12:00 AM EDT
8.42 Day range 9.25
8.42 52-week range 12.68
News
investorplace.com Why Is Science 37 (SNCE) Stock Up 9% Today? Science 37 (NASDAQ: SNCE ) stock is rising higher on Monday following news of inducement equity awards for its Metasite employees. According to a press release from Science 37, the awards were…
seekingalpha.com Science 37 Holdings, Inc. (SNCE) CEO David Coman on Q4 2021 Results - Earnings Call Transcript Science 37 Holdings, Inc. (SNCE) CEO David Coman on Q4 2021 Results - Earnings Call Transcript
seekingalpha.com Science 37: Pioneering Decentralized Clinical Trials Science 37 pioneered the concept of decentralized clinical trials. The Covid-19 pandemic drove more demand for DCTs.
benzinga.com 'SPACs Attack' Recap: Looking Back At 5 SPAC Deals, Rumors And Top Headlines Last week featured five announced SPAC deals and several rumors. The week also had earnings from several well-known former SPACs.
benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday's morning session, 92 stocks hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Highs On Wednesday Before 10 a.m. ET on Wednesday, 285 companies set new 52-week highs.
seekingalpha.com U.S. IPO Weekly Recap: Breast Cancer Biotech Pops 158% In A 6-IPO Week In a scramble to go public ahead of the holiday, six IPOs and 15 SPACs went public this past week led by breast cancer biotech Olema Pharmaceuticals, which soared 158% on its first day. New filings…
globenewswire.com LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering NEW YORK, Nov. 20, 2020 (GLOBE NEWSWIRE) -- LifeSci Acquisition II Corp. (NASDAQ: LSAQ), a blank check company targeting the biopharma sector, announced today that it priced its initial public…